{
    "title": "114_hr2391",
    "content": "The Act titled \"Medicaid Generic Drug Price Fairness Act of 2015\" applies the Medicaid additional rebate requirement to generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 applies an additional rebate requirement to generic drugs under Section 1927(c)(3) of the Social Security Act. The rebate amount for non-single source or innovator multiple source drugs is increased in a similar manner to single source or innovator multiple source drugs, with special rules for application. The Medicaid Generic Drug Price Fairness Act of 2015 applies special rules for applying additional rebate requirements to generic drugs under Section 1927(c)(3) of the Social Security Act. The Act adjusts references to specific dates and quarters to reflect changes in the drug market since 1990. The Medicaid Generic Drug Price Fairness Act of 2015 adjusts references to specific dates and quarters for generic drugs under Section 1927(c)(3) of the Social Security Act. References to certain dates and drug types are updated to reflect changes in the drug market since 1990. The Medicaid Generic Drug Price Fairness Act of 2015 updates references for generic drugs under Section 1927(c)(3) of the Social Security Act. It adjusts dates and quarters for noninnovator multiple source drugs sold after a specific timeframe. The term \"applicable quarter\" is defined for drugs falling under this category. The Medicaid Generic Drug Price Fairness Act of 2015 updates references for generic drugs under Section 1927(c)(3) of the Social Security Act, specifying the effective date for rebate periods starting after December 31, 2014."
}